Bumetanide Tablet
Product Images NDC 55154-3572

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 55154-3572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (9bd4fcd3 3020 41f2 B112 023b5db4487d 00)

Bumetanide tablets, USP 1 mg oral tablets packaging label showing a unit dose of 10 tablets. The label includes storage instructions, dosage advisory, warnings about child resistance and institutional use, and manufacturer details indicating Amneal Pharmaceuticals Pvt. Ltd. in India, with distribution by Amneal Pharmaceuticals LLC in New Jersey and Cardinal Health in Ohio. The NDC is 55154-3572-0.*

FDA Label Image

Structure (Bumetanide Tablets 1)

Chemical structure of Bumetanide showing its molecular arrangement with functional groups including sulfonamide, carboxylic acid, and aromatic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.